REG - Young & Co's Brew. - Update on Move to the Main Market

Young & Cos BreweryAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260325:nRSY9554Xa&default-theme=true

RNS Number : 9554X  Young & Co's Brewery PLC  25 March 2026

RNS Number: 9554X

Young & Co.'s Brewery, P.L.C.

25 March 2026

THIS ANNOUNCEMENT IS MADE FOR INFORMATION PURPOSES ONLY AND DOES NOT
CONSTITUTE OR FORM PART OF, AND SHOULD NOT BE CONSTRUED AS, AN OFFER TO SELL
OR ISSUE OR SOLICITATION TO BUY, SUBSCRIBE FOR OR OTHERWISE ACQUIRE ANY SHARES
IN YOUNG & CO.'S BREWERY, P.L.C. IN ANY JURISDICTION.

 

YOUNG & CO.'S BREWERY, P.L.C. ("Young's" or the "Company")

 

UPDATE ON MOVE TO THE MAIN MARKET

Young's, the premium operator of pubs and bedrooms in London and the South of
England, today provides an update on the proposed admission of: (i) its entire
issued A ordinary share capital (the "A Ordinary Shares") to the equity shares
(commercial companies) category (the "ESCC") of the Official List of the FCA
(the "Official List"); (ii) its entire issued non‑voting ordinary share
capital (the "Non-Voting Ordinary Shares", together with the A Ordinary
Shares, the "Ordinary Shares") to the non‑equity shares and non‑voting
equity shares category of the Official List; and (iii) the Ordinary Shares to
trading on the main market for listed securities of the London Stock Exchange
(the "Main Market") (together "Admission").

Further to its announcement on 22 January 2026, the Company now expects that:
(i) Admission will take place at 8.00 a.m. on 28 April 2026; and (ii) the
Ordinary Shares will be cancelled from trading on AIM at 8.00 a.m. on 28 April
2026. The last day of trading in the Ordinary Shares on AIM is therefore
expected to be 27 April 2026. Admission will be effected through an
introduction of the Company's existing Ordinary Shares and the Company is not
offering any new Ordinary Shares nor any other securities in connection with
the proposed Admission. Accordingly, the Company hereby gives notice of the
intended cancellation of trading of its Ordinary Shares on AIM in accordance
with Rule 41 of the AIM Rules for Companies. Such cancellation is not subject
to shareholder approval.

Admission remains subject to a number of conditions, including: (i) the
approval by the FCA of a prospectus and the A Ordinary Shares being admitted
by the FCA to the ESCC category of the Official List and the Non‑Voting
Ordinary Shares being admitted by the FCA to the non‑equity shares and
non‑voting equity shares category of the Official List; and (ii) admission
by the London Stock Exchange of the Ordinary Shares to trading on the Main
Market.

Shareholders should note that the Ordinary Shares will no longer be traded on
AIM with effect from Admission and should take their own financial and
taxation advice regarding the consequences of Admission.

Peel Hunt and Stifel are acting as Joint Sponsors exclusively to the Company
and no one else in connection with the proposed Admission.

 

Further announcements will be made in due course.

 

 

For further information, please contact:

 

 Young & Co.'s Brewery, P.L.C.                                            020 8875 7000

 Simon Dodd, Chief Executive Officer

 Michael Owen, Chief Financial Officer

 Peel Hunt - Nominated Adviser, Joint Sponsor and Joint Corporate Broker  020 7418 8900
 George Sellar / Andrew Clark / Finn Nugent

 Stifel - Joint Sponsor and Joint Corporate Broker                        020 7710 7600
 Erik Anderson / Francis North / Jason Grossman / Ben Good

 MHP Group - Financial PR                                                 07770 753 544

 Tim Rowntree / Eleni Menikou / Charles Hirst

 

Important information

Neither this announcement, nor any copy of it, may be taken or transmitted,
published or distributed, directly or indirectly, in or into or from the
United States, Australia, Canada, Japan or the Republic of South Africa or any
other jurisdiction where to do so would constitute a violation of the relevant
securities laws of such jurisdiction. This announcement is for information
purposes only and does not constitute an offer to sell or issue, or the
solicitation of an offer to buy, acquire or subscribe for any Ordinary Shares
in any jurisdiction. Any failure to comply with these restrictions may
constitute a violation of the securities laws of such jurisdictions.

The Ordinary Shares have not been, and will not be, registered under the US
Securities Act of 1933, as amended (the "US Securities Act"), or under any
securities laws of any state or other jurisdiction of the United States and
may not be offered, sold, resold, transferred or delivered, directly or
indirectly, in or into or from the United States except pursuant to an
applicable exemption from, or in a transaction not subject to, the
registration requirements of the US Securities Act and in compliance with the
securities laws of any state or other jurisdiction of the United States. There
will be no offering of Ordinary Shares in the United States or in any other
jurisdiction in connection with Admission.

This announcement may include statements, beliefs or opinions that are, or may
be deemed to be, "forward-looking statements". These forward-looking
statements may be identified by the use of forward-looking terminology,
including the terms "believes", "estimates", "plans", "projects",
"anticipates", "targets", "aims", "continues", "expects", "intends", "hopes",
"may", "will", "would", "could" or "should" or, in each case, their negative
or other variations or comparable terminology, or by discussions of strategy,
plans, objectives, goals, future events or intentions. No representation or
warranty is made that any of these statements or forecasts will come to pass
or that any forecast results will be achieved. Forward-looking statements may
and often do differ materially from actual results. Any forward-looking
statements contained in the announcement speak only as of their respective
dates, reflect the Company's current view with respect to future events and
are subject to risks relating to future events and other risks, uncertainties
and assumptions relating to the Company's business, results of operations,
financial position, liquidity, prospects, growth and strategies.

Except as required by any applicable law or regulation, Young's expressly
disclaims any obligation or undertaking to release publicly any updates or
revisions to any forward-looking statements contained in this announcement or
any other forward-looking statements it may make whether as a result of new
information, future developments or otherwise.

Peel Hunt LLP ("Peel Hunt"), which is authorised and regulated in the United
Kingdom by the FCA, is acting exclusively for the Company and no one else in
connection with Admission, the contents of this announcement or any other
matters described in this announcement and will not regard any other person as
its client in relation to Admission, the content of this announcement or any
other matters described in this announcement and will not be responsible to
anyone other than the Company for providing the protections afforded to its
clients or for providing advice in relation to Admission, the content of this
announcement or any other matters referred to in this announcement.

Stifel Nicolaus Europe Limited ("Stifel", together with Peel Hunt, the "Joint
Sponsors"), which is authorised and regulated in the United Kingdom by the
FCA, is acting exclusively for the Company and no one else in connection with
Admission, the contents of this announcement or any other matters described in
this announcement and will not regard any other person as its client in
relation to Admission, the content of this announcement or any other matters
described in this announcement and will not be responsible to anyone other
than the Company for providing the protections afforded to its clients or for
providing advice in relation to Admission, the content of this announcement or
any other matters referred to in this announcement.

Apart from the responsibilities and liabilities, if any, which may be imposed
on the Joint Sponsors by FSMA or the regulatory regime established thereunder
or under the regulatory regime of any other applicable jurisdiction where
exclusion of liability under the relevant regulatory regime would be illegal,
void or unenforceable, neither of the Joint Sponsors nor any of their
affiliates accept any responsibility whatsoever (whether direct or indirect,
whether in contract, in tort, under statute or otherwise) to any person in
connection with this announcement, any statement contained herein or
otherwise, nor makes any representation or warranty, express or implied, in
relation to, the contents of this announcement, including its accuracy,
completeness or verification or for any other statement made or purported to
be made by the Company, or the Joint Sponsors, or on their behalf, in
connection with the Company or its subsidiaries, the Ordinary Shares or
Admission. The Joint Sponsors and each of their affiliates accordingly
disclaim, to the fullest extent permitted by applicable law, all and any
liability whether arising in tort, contract or otherwise (save as referred to
above) which they might otherwise be found to have in respect of this
announcement or any such statement. No representation or warranty, express or
implied, is made by either of the Joint Sponsors or any of their affiliates as
to the accuracy, completeness, verification or sufficiency of the information
set out in this announcement, and nothing in this announcement will be relied
upon as a promise or representation in this respect, whether or not to the
past or future.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  UPDUSANRNOUOUAR



            Copyright 2019 Regulatory News Service, all rights reserved